They took their research further and discovered that these benefits were available to humans, too
Of particular concern are new findings linking semaglutide-based medications, including Ozempic, Wegovy, and Rybelsus, to a rare but devastating eye condition
Studies show GLP-1 + exercise produces greater metabolic retention and functional outcomes ( BioMed Central )
Victoza was approved in 2010, but in 2013, the FDA issued a warning to consumers of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas. But we dont have to look at previous generations of GLP-1s so see the risk that unknown side effects have
Their clinical trials (NCT04542161) conclusively demonstrated that ME/CFS patients suffer from a significant, localized deficit of glutathione in the cerebral cortex, directly correlating with the severity of their neuroinflammation and cognitive dysfunction